apree health Appoints Marla McLaughlin as Chief Medical Officer

apree health, a MosaicHealth company, and the leader in transformative healthcare solutions, today announced that Marla McLaughlin, MD has been named chief medical officer (CMO) for the company and its Castlight Health and Vera Whole Health brands. McLaughlin, who previously served as associate CMO, will now lead apree health's initiatives to strengthen clinical operations, improve

AI RAN to Top $10 Billion by 2029, According to Dell’Oro Group

D-RAN, Single-Purpose, and 5G to Shape AI RAN Market According to a brand-new AI RAN Advanced Research Report published by Dell'Oro Group, the trusted source for market information about the telecommunications, security networks, and data center industries, AI RAN is projected to account for approximately a third of the RAN market by 2029. In the

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Vishay Intertechnology, Inc.(NYSE: VSH) and Encourages Long-Term VSH Investors to Contact the Firm

Kaskela Law LLC announces that it is investigating Vishay Intertechnology, Inc.(NYSE: VSH) (“Vishay”) on behalf of the company's long-term investors. https://mma.prnewswire.com/media/1088088/Kaskela_Law_Logo.jpg The investigation seeks to determine whether Vishay and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Vishay shareholders are encouraged to contact

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of National HealthCare Corporation (NYSE: NHC) and Encourages Long-Term NHC Investors to Contact the Firm

Kaskela Law LLC announces that it is investigating National HealthCare Corporation (NYSE: NHC) (“NHC”) on behalf of the company's long-term investors. https://mma.prnewswire.com/media/1088088/Kaskela_Law_Logo.jpg Since November 2024, shares of NHC's common stock have declined in value from a trading price of over $135.00 per share to a current trading price of below $110.00 per share, a decline

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the Firm

Kaskela Law LLC announces that it is investigating Amicus Therapeutics, Inc. (NASDAQ: FOLD) (“Amicus”) on behalf of the company's shareholders. https://mma.prnewswire.com/media/1088088/Kaskela_Law_Logo.jpg Year to date, shares of Amicus' stock have declined over 32% in value, to trade at a current price of less than $7.00 per share. The investigation seeks to determine whether Amicus and/or the

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of First American Financial Corp. (NYSE: FAF) and Encourages Long-Term FAF Investors to Contact the Firm

Kaskela Law LLC announces that it is investigating First American Financial Corp. (NYSE: FAF) (“First American”) on behalf of the company's long-term investors. https://mma.prnewswire.com/media/1088088/Kaskela_Law_Logo.jpg Since November 2024, shares of the company's stock have declined from a trading price of over $70.00 per share to a current trading price of under $62.00, a decline of over

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of MaxLinear, Inc. (NASDAQ: MXL) and Encourages Long-Term MXL Investors to Contact the Firm

Kaskela Law LLC announces that it is investigating MaxLinear, Inc. (NASDAQ: MXL) on behalf of the company's long-term investors. https://mma.prnewswire.com/media/1088088/Kaskela_Law_Logo.jpg Year to date, shares of MaxLinear's stock are down 25% in value, to trade at a current price of approximately $15.00 per share. The investigation seeks to determine whether MaxLinear and/or the company's officers and

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Solid Biosciences Inc. (NASDAQ: SLDB) and Encourages Long-Term SLDB Investors to Contact the Firm

The law firm of Kaskela Law LLC announces that it is investigating Solid Biosciences Inc. (NASDAQ: SLDB) on behalf of the company's shareholders. https://mma.prnewswire.com/media/1088088/Kaskela_Law_Logo.jpg Since September 2024, shares of Solid Biosciences' stock have declined in value from a trading price of over $10.00 per share to a current trading price of less than $6.00 per

Corsha Secures Strategic Investment from Booz Allen

Booz Allen and Corsha join forces to secure the machine identity layer – a rapidly growing and underserved market – for mission-critical operational systems Corsha, the first and only Machine Identity Provider (mIDP) purpose-built to secure machine-to-machine (M2M) communication across operational systems and critical infrastructure, today announced a strategic investment from Booz AllenVentures, the corporate

Scroll to Top